Trial site
Miami Dade Medical Research Institute, LLC
- 3running trials
- 9closed trials
The trials here
What the 12 trials at this site are about, from their registry records.
- Conditions
- Chronic spontaneous urticaria2 trials
- Alzheimer disease1 trial
- Atopic dermatitis (eczema)1 trial
- Gout1 trial
- Type 2 diabetes1 trial
- Phase
- Phase 38 trials
- Phase 1/22 trials
- Phase 22 trials
- Status
- Completed9 trials
- Active, not recruiting2 trials
- Enrolling by invitation1 trial
- Lead sponsor
- BioNTech SE4 trials
- Celldex Therapeutics2 trials
- Eli Lilly and Company2 trials
- Amgen1 trial
- Boehringer Ingelheim1 trial
- and 2 more
Running trials
Enrolling by invitation
Active, not recruiting
A Phase 3 Study of Barzolvolimab in Participants With Chronic Spontaneous Urticaria
Active, not recruiting
A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2)
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Chronic spontaneous urticaria1 recruiting
Closed trials
Completed
A Study to Learn About How the Flu and COVID-19 Vaccines Act in Healthy People
Completed
A Study to Learn About Flu and COVID-19 Vaccine Responses in Healthy People
Completed
Completed
Completed
Tigulixostat, Phase 3 Study, Allopurinol Controlled in Gout Patients
Completed
Completed
Completed
A Study to Evaluate a Modified RNA Vaccine Against Influenza in Adults 18 Years of Age or Older
Completed
Site data: ClinicalTrials.govUpdated 17 Nov 2026